Theriva Biologics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Theriva Biologics, Inc. (TOVX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.61 million shares for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2016-08-03
- Theriva Biologics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-03-31 was 8.99M shares, a 37.69% increase year-over-year.
- Theriva Biologics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-03-31 was 6.53M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2016-06-30 | 8.61M shares 10-Q · filed 2016-08-03 | |
| 2016-03-31 | 8.99M shares 10-Q · filed 2016-05-05 | |
| 2015-06-30 | 7.47M shares 10-Q · filed 2016-08-03 | |
| 2015-03-31 | 6.53M shares 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |